UK/EU Electricity ─ Not Defensive: Hardman Monthly Report

Hardman & Co ReportOur key feature this month is a review of the UK/EU Electricity sector by Nigel Hawkins who has recently joined Hardman to cover the utilities and renewable energy market. Nigel has had a long career in the City covering both industries having worked at Hoare Govett covering water and electricity privatisation, and at Yamaichi and W de Bröe.

The main conclusions are:
► Despite a number of key government initiatives across Europe to encourage new investment by smaller companies, the electricity industry remains dominated by the very large corporates.

► Falling demand has caused power prices to fall sharply, especially in Germany.

► Most of the larger energy companies have given priority to reducing high debt levels, either selling non-core assets or in some cases reducing dividends.

► Electricity generating companies are no longer regarded as defensive assets as investors in RWE and E.On have discovered.

► Over the past decade a shift to renewable generation, aided by generous public subsidies, has been a notable feature of the UK/EU energy landscape.

This months report contains research for the following companies:
► Advanced Oncotherapy Plc
► Allergy Therapeutics Plc
► Alliance Pharma Plc
► Avacta
► Burford Capital
► City of London Investment Group
► Grafenia
► Lombard Risk Management
► MedicX Fund
► Murgitroyd
► PPHE Hotel Group
► Primary Health Properties
► Premaitha Health
► Purplebricks
► Real Good Food
► Redx Pharma
► Tethys Oil AB
► Tissue Regenix
► Titon Holdings
► Verona Pharma

Click to view all articles for the EPIC: ,
Or click to view the full company profile:
Facebook
X
LinkedIn
Hardman & Co

More articles like this

Hardman & Co

Advanced Oncotherapy: Understanding the significance of 230MeV

Advanced Oncotherapy plc (LON:AVO) goal is to deliver an affordable and novel PT system, called LIGHT, based on state-of-the-art technology, developed originally at the world-renowned CERN. The complex assembly of the first LIGHT accelerator in Daresbury

Allergens dominate UK food recalls, finds study

More than half of food recalls in the United Kingdom over a 5-year period were due to allergens, according to a recently released study. Allergen-related recalls increased annually until 2019, peaking at 118 before decreasing to

Allergy Therapeutics welcomes new Non-Executive Directors

Allergy Therapeutics announced the appointments of Anthony Parker and Simon Shen to its Board as Non-Executive Directors effective immediately. “I would like to welcome Anthony and Simon. Southern Fox and ZQ Capital have been long-standing and supportive shareholders of Allergy

Allergy Therapeutics updates on its clinical programmes

Allergy Therapeutics plc (LON:AGY), the fully integrated commercial biotechnology company specialising in allergy vaccines, has announced that the first subject has been dosed in the pivotal Phase III G306 trial, to evaluate the efficacy and safety of

Allergy Therapeutics appoints two Non-Executive Directors

Allergy Therapeutics plc (LON:AGY), the fully integrated commercial biotechnology company specialising in allergy vaccines, has today announced the appointments of Anthony Parker and Zheqing (Simon) Shen as Non-Executive Directors of the Company, with immediate effect. Anthony represents

Allergies and Thanksgiving

As Thanksgiving and other holiday celebrations bring people around the table, Intermountain Healthcare dietitians say it’s crucial to take food allergies into consideration when planning the big meal. “A response to an allergic reaction can be

Allergy Therapeutics appoints Martin Hopcroft as interim CFO

Allergy Therapeutics plc (LON:AGY), the fully integrated commercial biotechnology company specialising in allergy vaccines, has announced the appointment of Martin Hopcroft to the role of Interim Chief Financial Officer (CFO). Martin will report into Chief Executive

Food business operator fined for allergy breach

A food business operator based in Newcastle, England has been fined in court after serving a dish containing peanuts to a woman with a peanut allergy, resulting in her being hospitalised. According to the Food Standards

Are restaurants taking allergies seriously?

In an engaging panel held at Twickenham Stadium as part of New Food’s Food Safety Conference 2022, experts came together to debate whether food allergy regulations in restaurants are sufficient. Here’s the highlights. Are restaurant allergy